These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 15285746

  • 1. Clinical characteristics of normotensive renal transplant recipients with microalbuminuria and effects of angiotensin II type I receptor antagonist on urinary albumin excretion.
    Satoh S, Horikawa Y, Kakinuma H, Tsuchiya N, Wang L, Kato T, Habuchi T.
    Int J Urol; 2004 Aug; 11(8):585-91. PubMed ID: 15285746
    [Abstract] [Full Text] [Related]

  • 2. Use of losartan in reducing microalbuminuria in normotensive patients with type-2 diabetes mellitus.
    Agha A, Bashir K, Anwar E.
    Nepal Med Coll J; 2007 Jun; 9(2):79-83. PubMed ID: 17899953
    [Abstract] [Full Text] [Related]

  • 3. Low-grade albuminuria reduction with angiotensin II type 1 receptor blocker in renal transplant recipients.
    Uchida J, Machida Y, Iwai T, Iguchi T, Kamada Y, Naganuma T, Kumada N, Kim T, Kawashima H, Nakatani T.
    J Nephrol; 2011 Jun; 24(4):515-21. PubMed ID: 21240871
    [Abstract] [Full Text] [Related]

  • 4. Reduction of microalbuminuria by using losartan in normotensive patients with type 2 diabetes mellitus: A randomized controlled trial.
    Agha A, Amer W, Anwar E, Bashir K.
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):429-35. PubMed ID: 19414946
    [Abstract] [Full Text] [Related]

  • 5. Aldosterone synthase (CYP11B2)-344T/C polymorphism and renoprotective response to losartan treatment in diabetic nephropathy.
    Schjoedt KJ, Lajer M, Andersen S, Tarnow L, Rossing P, Parving HH.
    Scand J Clin Lab Invest; 2006 May; 66(3):173-80. PubMed ID: 16714246
    [Abstract] [Full Text] [Related]

  • 6. Effects of angiotensin II receptor blocker on proteinuria in renal transplant recipients.
    Tanji N, Ohoka H, Shimamoto K, Ikeda T, Miyauchi Y, Yokoyama M.
    In Vivo; 2004 May; 18(4):433-6. PubMed ID: 15369180
    [Abstract] [Full Text] [Related]

  • 7. Renal effects of long-term leptin infusion and preventive role of losartan treatment in rats.
    Gunduz Z, Dursun N, Akgun H, Ozturk F, Okur H, Koc N.
    Regul Pept; 2005 Dec 15; 132(1-3):59-66. PubMed ID: 16229907
    [Abstract] [Full Text] [Related]

  • 8. Urinary protein excretion and renal function in young people with diabetes mellitus.
    Widstam-Attorps U, Berg U.
    Nephrol Dial Transplant; 1992 Dec 15; 7(6):487-92. PubMed ID: 1320227
    [Abstract] [Full Text] [Related]

  • 9. Randomized, controlled study of the effects of losartan versus enalapril in small doses on proteinuria and tubular injury in primary glomerulonephritis.
    Tylicki L, Renke M, Rutkowski P, Rutkowski B, Lysiak-Szydłowska W.
    Med Sci Monit; 2005 Apr 15; 11(4):PI31-7. PubMed ID: 15795705
    [Abstract] [Full Text] [Related]

  • 10. Melatonin reduces urinary excretion of N-acetyl-beta-D-glucosaminidase, albumin and renal oxidative markers in diabetic rats.
    Oktem F, Ozguner F, Yilmaz HR, Uz E, Dündar B.
    Clin Exp Pharmacol Physiol; 2006 Apr 15; 33(1-2):95-101. PubMed ID: 16445706
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Antihypertensive and renoprotective efficacy and safety of losartan. A long-term study in children with renal disorders.
    Ellis D, Moritz ML, Vats A, Janosky JE.
    Am J Hypertens; 2004 Oct 15; 17(10):928-35. PubMed ID: 15485756
    [Abstract] [Full Text] [Related]

  • 13. Effect of lacidipine, a dihydropyridine calcium antagonist on renal function of hypertensive patients with renal insufficiency.
    Bailey RR, Shand BI, Smith AH, Robson RA, Lynn KL.
    Clin Nephrol; 1997 Oct 15; 48(4):224-9. PubMed ID: 9352156
    [Abstract] [Full Text] [Related]

  • 14. Effect of losartan on microalbuminuria in normotensive patients with type 2 diabetes mellitus. A randomized clinical trial.
    Zandbergen AA, Baggen MG, Lamberts SW, Bootsma AH, de Zeeuw D, Ouwendijk RJ.
    Ann Intern Med; 2003 Jul 15; 139(2):90-6. PubMed ID: 12859158
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of pentoxifylline in addition to losartan on proteinuria and GFR in CKD: a 12-month randomized trial.
    Lin SL, Chen YM, Chiang WC, Wu KD, Tsai TJ.
    Am J Kidney Dis; 2008 Sep 15; 52(3):464-74. PubMed ID: 18617301
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the influence of angiotensin-converting enzyme inhibitor lisinopril and angiotensin II receptor antagonist losartan in patients with idiopathic membranous nephropathy and nephrotic syndrome.
    Kosmadakis G, Filiopoulos V, Georgoulias C, Tentolouris N, Michail S.
    Scand J Urol Nephrol; 2010 Sep 15; 44(4):251-6. PubMed ID: 20201749
    [Abstract] [Full Text] [Related]

  • 18. Urinary excretion rates of multiple renal indicators after kidney transplantation: clinical significance for early graft outcome.
    Matteucci E, Carmellini M, Bertoni C, Boldrini E, Mosca F, Giampietro O.
    Ren Fail; 1998 Mar 15; 20(2):325-30. PubMed ID: 9574459
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Determinants of urinary albumin excretion reduction in essential hypertension: A long-term follow-up study.
    Pascual JM, Rodilla E, Miralles A, Gonzalez C, Redon J.
    J Hypertens; 2006 Nov 15; 24(11):2277-84. PubMed ID: 17053551
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.